These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 35384369)

  • 1. Milrinone or dobutamine in patients with heart failure: evidence from meta-analysis.
    Szarpak L; Szwed P; Gasecka A; Rafique Z; Pruc M; Filipiak KJ; Jaguszewski MJ
    ESC Heart Fail; 2022 Jun; 9(3):2049-2050. PubMed ID: 35384369
    [No Abstract]   [Full Text] [Related]  

  • 2. A bridge for the 21st century in heart transplantation?
    Felker GM; O'connor CM
    Am Heart J; 2003 Feb; 145(2):198-9. PubMed ID: 12595831
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of Inpatient Dobutamine versus Milrinone on Out-of-Hospital Mortality in Patients with Acute Decompensated Heart Failure.
    King JB; Shah RU; Sainski-Nguyen A; Biskupiak J; Munger MA; Bress AP
    Pharmacotherapy; 2017 Jun; 37(6):662-672. PubMed ID: 28475215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Positive Inotropic Agents in the Management of Acute Decompensated Heart Failure.
    Kelly J; Cheng J; Malloy R; Lupi K
    J Cardiovasc Pharmacol; 2020 May; 75(5):455-459. PubMed ID: 32091426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of milrinone with dobutamine in patients undergoing cardiac surgery: a systematic review and meta-analysis.
    Alkadri J; Hu R; Jeffers MS; Ross J; McIsaac DI; McDonald B
    Can J Anaesth; 2023 Jul; 70(7):1272-1274. PubMed ID: 37160823
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
    Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
    Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes associated with vasoactive therapy in patients with acute decompensated heart failure.
    Arnold LM; Crouch MA; Carroll NV; Oinonen MJ
    Pharmacotherapy; 2006 Aug; 26(8):1078-85. PubMed ID: 16863484
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis Comparing the Efficacy of Dobutamine Versus Milrinone in Acute Decompensated Heart Failure and Cardiogenic Shock.
    Biswas S; Malik AH; Bandyopadhyay D; Gupta R; Goel A; Briasoulis A; Fonarow GC; Lanier GM; Naidu SS
    Curr Probl Cardiol; 2023 Aug; 48(8):101245. PubMed ID: 35545181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intermittent inotropes for advanced heart failure: inquiring minds want to know.
    Silver MA
    Am Heart J; 1999 Aug; 138(2 Pt 1):191-2. PubMed ID: 10426825
    [No Abstract]   [Full Text] [Related]  

  • 10. Palliative Inotropes in Advanced Heart Failure: Comparing Outcomes Between Milrinone and Dobutamine.
    Sami F; Acharya P; Noonan G; Maurides S; Al-Masry AA; Bajwa S; Parimi N; Boda I; Tran C; Goyal A; Mastoris I; Dalia T; Sauer A; Bakel AV; Shah Z
    J Card Fail; 2022 Dec; 28(12):1683-1691. PubMed ID: 36122816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes.
    Bayram M; De Luca L; Massie MB; Gheorghiade M
    Am J Cardiol; 2005 Sep; 96(6A):47G-58G. PubMed ID: 16181823
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy.
    Liu L; Zhao SP
    Int J Cardiol; 1999 Apr; 69(1):77-82. PubMed ID: 10362376
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Milrinone therapy in catecholamine-dependent critically ill patients with heart failure.
    Siostrzonek P; Koreny M; Delle-Karth G; Haumer M; Koller-Strametz J; Heinz G
    Acta Anaesthesiol Scand; 2000 Apr; 44(4):403-9. PubMed ID: 10757572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
    Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
    Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intraoperative milrinone versus dobutamine in cardiac surgery patients: a retrospective cohort study on mortality.
    Nielsen DV; Torp-Pedersen C; Skals RK; Gerds TA; Karaliunaite Z; Jakobsen CJ
    Crit Care; 2018 Feb; 22(1):51. PubMed ID: 29482650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current views on Milrinon--a PDE-III-inhibitor].
    Anaesthesist; 1994 Mar; 43(3 Suppl):1-16. PubMed ID: 9209531
    [No Abstract]   [Full Text] [Related]  

  • 17. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
    Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
    Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inotropic therapy in heart failure: general aspects and clinical results].
    Manito N; Kaplinsky EJ; Pujol R
    Med Clin (Barc); 2004 Feb; 122(7):269-74. PubMed ID: 15012878
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rotating inotrope therapy in a pediatric population with decompensated heart failure.
    Ryerson LM; Alexander PM; Butt WW; Shann FA; Penny DJ; Shekerdemian LS
    Pediatr Crit Care Med; 2011 Jan; 12(1):57-60. PubMed ID: 20453705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine.
    Nuñez S; Maisel A
    Am Heart J; 1998 Mar; 135(3):383-8. PubMed ID: 9580093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.